ACAntonella Cassinari

Antonella Cassinari

*This is an algorithmically generated author record based on publicly available information.

Antonella Cassinari has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Antonio Maconi

    Research Training Innovation Infrastructure, Research and Innovation Department (DAIRI), Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo, Alessandria

    4 shared publications
  • Marianna Farotto

    Research and Innovation Department (DAIRI), Azienda Sanitaria Locale (ASL), Alessandria

    3 shared publications
  • Marinella Bertolotti

    SSD Research Laboratories, Research and Innovation Department (DAIRI), Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo, Via Venezia 16, 15121 Alessandria, Italy

    3 shared publications
  • Marta Betti

    Dipartimento Attività integrate ricerca e innovazione (Dairi), Azienda ospedaliero-universitaria SS. Antonio e Biagio e Cesare Arrigo, Alessandria

    3 shared publications
  • Annalisa Roveta

    Research Laboratories, Research and Innovation Department, Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy

    2 shared publications
  • Antonio Maconi

    Research Training Innovation Infrastructure, Research and Innovation Department (DAIRI), Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo, Via Venezia 16, 15121 Alessandria, Italy

    2 shared publications

Latest Publications

  • Open Access

    Assessment of psychosocial and neuropsychological variables in patients with neurocognitive disorders and chronic stress in caregivers

    by Antonio Pepoli, Marinella Bertolotti, Antonella Cassinari, Chiara Demaria, Marianna Farotto, Monica Franscini, Simona Giribone, Valentina Manfredi, Elisa Messina, Rossella Sterpone, et al.

    Background: nowadays, there are plenty of programs and resources to prevent caregiver bur-den of patients with Alzheimer’s disease. In spite of that, many caregivers suffer high levels of burden and stress, which leads to an earlier institutionalization of patients. This study aimed to explore how behavioral modules specific to Alzheimer's disease impact caregiver burden. Materials and Methods: a longitudinal (T0-T1, follow up) dyadic design was adopted and a sample of 76 patient-caregiver dyads was recruited. Correlational analyses were used to model associations between variables. Burden was measured with a Caregiver Burden Inventory. Measures of patients’ cognition, insight, depression, behavioral disturbances and functional ability were considered with specific scales (Cornell; Clinical Dementia Rating scale, CDR; Clinical Insight Rating Scale, CIRS). Results: we found that there are behavioral modules specific to Alzheimer's disease that nega-tively influence the psycho-physical state of caregiver health. These include patient's mood (r=0.4; p=0.001), behavioral changes (r=0.4; p<0.001), cyclical functions (r=0.3; p=0.007) and social isolation (r=0.3; p=0.02). Conclusions: despite study limits, interventions to reduce burden should be adapted to the spe-cific needs of the Alzheimer patient and caregiver.

  • Open Access

    Medication adherence in patients with carotid artery stenosis before/after enrollment in CARUSO study

    by Michela Lanza, Tiziana Aranzulla, Antonella Cassinari, Giuseppe Musumeci, Andrea Gaggiano, Marianna Farotto, Carlotta Bertolina, Marinella Bertolotti, Antonio Maconi, Alberto Guagliano

    Background: this work analyses the medical therapy adherence of patients enrolled in a clinical study. The primary end- point of this research is to find out if enrolment in a clinical study can improve adherence to antiplatelet and/or lipid- lowering therapy.Materials and Methods: the first 92 asymptomatic patients with carotid artery stenosis ≥50% enrolled in the CARUSO study were considered. Overall baseline “compliance” to anti-platelet treatment was stratified in patients with good, average, and poor adherence. Results: overall compliance with anti-platelet therapy was good for 66 patients (95.7%) out of 69 patients already under this treatment. A significant correlation between good adherence to pharmacological therapy and the presence of previ- ous cardiovascular events at the time of enrolment: 92.3% (one event), 84.6% (two events), 50% (three events) vs 35.1% of those without events (p 95%) of adherence to anti-platelet therapy, after the enrolment in a clinical study.

  • Open Access

    Analysis of geographical distribution of high-grade glioma diagnoses in the Alessandria province: pilot study preliminary results

    by Marianna Farotto, Marinella Bertolotti, Antonella Cassinari, Roberta Libener, Carolina Pelazza, Marta Betti, Antonio Maconi

    Background: one under-researched line of investigation is gliomas, which are a group of malignant brain tumours with highly poor prognoses. Despite efforts to identify environmental risk factors for gliomas, their etiology still remains unclear. It turns out that several future developments are needed in order to understand other potential risk factors. To this end, the primary objective of the present pilot study is to conduct an assessment of the spatial distribution of high-grade brain tumor cases in the province of Alessandria, where possible risk factors such as the presence of chemical industries and asbestiform fibers are found. Materials and Methods: the study sample consisted of all patients diagnosed with high-grade glioma between January 2018 and April 2023, residents in the province of Alessandria at the time of diagnosis and referred to the health facilities of the "Azienda Sanitaria Locale di Alessandria" and the "Azienda Universitario-Ospedaliera di Alessandria". Biographical and pathological history variables were collected, and finally, data were processed in aggregate and anonymized form. A total of 103 deceased patients were enrolled, stratified by age and type of diagnosis. Results: it was seen that the city with the most cases was Alessandria, with 27 diagnoses found during the period under review (26.2%), followed by cities of Acqui Terme, Casale Monferrato, and Novi Ligure with seven diagnoses (6.8%). Preliminary results presented in this paper were compared with data already published. Conclusions: analyses performed to arrive at an initial geographical distribution of high-grade glioma diagnoses are consistent relative to the population density of each municipality considered.

  • Open Access

    Prognostic evaluation of KRAS and BRAF mutations in relation to Mismatch Repair protein status: preliminary survival analysis of patients with Colorectal Cancer

    by Carlotta Bertolina, Marinella Bertolotti, Antonella Cassinari, Riccardo Mazzucco, Carolina Pelazza, Marta Betti, Antonio Maconi

    Aims: prognostic impact of mutations in BRAF and KRAS genes in patients with colorectal cancer was evaluated to detect variations in survival among patients with these mutations, in relation to different morphologic features identified at diagnosis and the expression of mismatch repair proteins. The final purpose of the project will be to establish models to predict variations in survival in different subsets of patients with colorectal cancer. Materials and Methods: partial survival analyses were conducted on 32 subjects in relation to three different variables: mutation in BRAF or KRAS genes, expression of mismatch repair system and morphological features of the tumor. Results: preliminary results of this study provide evidence that survival in different subsets of patients with colorectal cancer can be influenced by several factors, which include, in addition to immunohistochemical and molecular investigations, the assessment of different morphological features. Conclusions: Integrating different characteristics may reveal which factors have a more significant impact on survival in these subgroups. More patients will be needed to design different survival models and to check these preliminary results more effectively. Obiettivi: l’impatto prognostico delle mutazioni nei geni BRAF e KRAS nei pazienti con tumore del colon-retto è stato valutato per individuare le variazioni di sopravvivenza tra i pazienti con queste mutazioni, in relazione alle diverse caratteristiche morfologiche identificate alla diagnosi ed all’espressione delle proteine di Mismatch Repair. Lo scopo finale del progetto sarà quello di stabilire modelli per prevedere le variazioni di sopravvivenza in diversi sottoinsiemi di pazienti con tumore del colon-retto. Materiali e Metodi: sono state condotte analisi di sopravvivenza parziale su 32 soggetti in relazione a tre diverse variabili: mutazione nei geni BRAF o KRAS, espressione delle proteine dei Mismatch Repair e caratteristiche morfologiche del tumore. Risultati: i risultati preliminari di questo studio dimostrano che la sopravvivenza in diverse sottopopolazioni di pazienti con tumore del colon-retto può essere influenzata da diversi fattori, che includono, oltre alle indagini immunoistochimiche e molecolari, la valutazione di diverse caratteristiche morfologiche. Conclusioni: l’integrazione di diverse caratteristiche può rivelare quali fattori abbiano un impatto più significativo sulla sopravvivenza in questi sottogruppi. Sarà necessario un numero maggiore di pazienti per progettare diversi modelli di sopravvivenza e verificare in maniera più efficace questi risultati preliminari.

  • Open Access

    SARS-CoV-2 vs Streptococcus pneumoniae: a comparison of clinical features, laboratory findings, and clinical outcomes in patients hospitalized at Alessandria’s General Hospital

    by Iacopo Megna, Serena Penpa, Antonella Cassinari, Christian Leli, Andrea Rocchetti, Annalisa Roveta, Marta Betti, Antonio Maconi

    Aims: the aim of the present study was to compare the clinical, anamnestic, and laboratory features and outcomes of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pneumonia and pneumonia caused by Streptococcus pneumoniae in hospitalized patients at the General Hospital of Alessandria, Italy. Materials and Methods: radiological diagnosis of pneumonia by chest X-ray and/or chest Computed Tomography (CT); microbiological diagnosis of SARS-CoV-2 infection by nasopharyngeal swab Reverse Transcriptase - Polymerase Chain Reaction (RT-PCR), etiological diagnosis of S. pneumoniae pneumonia by positive urinary antigen detection and/or isolation of S. pneumoniae from respiratory and/or blood cultures. Results: 222 patients were included, 171 with SARS-CoV-2 pneumonia and 51 with S. pneumoniae. SARS-CoV-2 group most frequently treated with antiviral drugs: 139/171 (81.3%) vs 1/51 (2.1%); p<0.001; they often needed oxygen therapy: 142/171 (83%) vs 27/51 (56.3%); p<0,001; and non-invasive mechanical ventilation: 59/171 (34.5%) vs 7/51 (14.6%); p=0.004. Mortality was higher in SARS-CoV-2 pneumonia patients: 46/171 (26.9%) than in pneumococcal pneumonia patients 5/51 (9.8%); p=0.011. Conclusions: the study showed the increased prevalence of pneumonia caused by SARS-CoV-2 and S. pneumoniae in males than in females. Moreover, patients with SARS-CoV-2 pneumonia represent higher risk group for complications and death than S. pneumoniae.

  • Open Access

    Analysis of lymphocyte subsets in COVID-19 patients: a retrospective observational study

    by Maria Matilde Ciriello, Nicoletta Tommasi, Costanza Massarino, Antonella Cassinari, Thea Bensi, Raffaella Doglio, Annalisa Roveta, Antonio Maconi

    In this retrospective study, we analyzed the possible predictive changes in lymphocyte subsets of Coronavirus Disease 19 (COVID-19) hospitalized patients. We enrolled 107 COVID-19 patients older than 18 years of age, admitted to Alessandria Hospital with a confirmed diagnosis of SARS-CoV-2 infection by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), who performed the analysis of lymphocyte subsets, between 2020 March 01 and 2021 May 31. Patients have been split up into two groups, based on clinical manifestations: group 1 non-severe disease (n=44) and group 2 severe disease (n=63), according to the World Health Organization (WHO) interim guidance. For the comparison between the two groups of patients, statistical significance was tested with the Mann-Whitney and the Chi-Square test. In the group of patients with severe disease, the blood cell analysis showed a significant reduction in the counts of total lymphocytes, absolute CD3 lymphocytes, and CD8 lymphocytes, as well as a significant reduction in monocyte percent and a very significant increase in neutrophil counts. From the results obtained, it can be stated that lymphocytopenia is associated with the progression of the disease and increased mortality.